Aurinia Pharmaceuticals Inc (AUPH)
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly Results
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates
A New Press Release from Theriva Biologics, Inc.
CNO Financial Indianapolis Monumental Marathon Expands to Largest Field Ever, Sells Out in Record Time
NREF Announces Second Quarter 2026 Results, Provides Third Quarter 2026 Guidance
RedCloud Signs Open Weights and American AI Leadership Letter Alongside Microsoft, NVIDIA and OpenAI
Valeo - Déclaration des droits de vote - Juillet 2026
Regency Centers Declares Quarterly Dividends
GXO veröffentlicht Ergebnisse für das zweite Quartal 2026
Oklo's Groves Reactor Achieves First Criticality in Under a Year